4.6 Article

Genetic Variations in the Vitamin D Binding Protein and Season-Specific Levels of Vitamin D Among Older Adults

Journal

EPIDEMIOLOGY
Volume 24, Issue 1, Pages 104-109

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/EDE.0b013e318276c4b0

Keywords

-

Funding

  1. State Ministry of Science, Research and Arts of Baden-Wurttemberg
  2. German Cancer Aid [108250]
  3. Dietmar-Hopp Foundation
  4. Helmholtz Society
  5. German Cancer Research Center

Ask authors/readers for more resources

Background: Vitamin D insufficiency is common among older adults. Genome-wide association studies have found an association between variants in the vitamin D binding protein and serum levels of vitamin D. The quantification of this association among older women and men and its potential variation by season remain unexplored. Methods: Serum levels of 25-hydroxyvitamin D [25(OH)D] and genetic variants in the vitamin D binding protein were analyzed in 2160 women and 1581 men age 50 to 74 years participating in a large population-based cohort study (ESTHER study-epidemiologic study assessing chances of prevention and early detection of various chronic diseases, including cancer among older adults) in Germany. Serum levels of 25(OH)D were assessed in relation to four single nucleotide polymorphisms (SNPs; rs4588, rs2282679, rs1155563, and rs12512631) by descriptive and multivariate analysis. Results: Both heterozygous and homozygous women and men carrying the rare allele with SNPs rs4588, rs2282679, or rs1155563 had lower levels of 25(OH)D in summer months than those homozygous for the wild-type alleles. Adjusted differences ranged from 5.1 to 5.4 nmol/l among heterozygous carriers of the rare alleles and from 8.8 to 9.6 nmol/l among homozygous carriers of the rare alleles. During winter months, 25(OH)D differences by genotype were smaller among women and not apparent among men. Conclusions: Older women and men living in a high-latitude region and carrying the rare alleles of SNPs rs4588, rs2282679, or rs1155563 seem to benefit less from higher levels of ultraviolet radiation during the summer season. (Epidemiology 2013;24: 104-109)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Real-world evidence for the effectiveness of vitamin D supplementation in reduction of total and cause-specific mortality

Sha Sha, Thi Mai Ngoc Nguyen, Sabine Kuznia, Tobias Niedermaier, Anna Zhu, Hermann Brenner, Ben Schoettker

Summary: A study on the UK Biobank cohort found that the use of vitamin D supplements is associated with lower all-cause mortality and reduced mortality from cancer, cardiovascular disease, and respiratory disease.

JOURNAL OF INTERNAL MEDICINE (2023)

Article Gastroenterology & Hepatology

Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases

Tomotaka Ugai, Naohiko Akimoto, Koichiro Haruki, Tabitha A. Harrison, Yin Cao, Conghui Qu, Andrew T. Chan, Peter T. Campbell, Sonja Berndt, Daniel D. Buchanan, Amanda J. Cross, Brenda Diergaarde, Steven J. Gallinger, Marc J. Gunter, Sophia Harlid, Akihisa Hidaka, Michael Hoffmeister, Hermann Brenner, Jenny Chang-Claude, Li Hsu, Mark A. Jenkins, Yi Lin, Roger L. Milne, Victor Moreno, Polly A. Newcomb, Reiko Nishihara, Mireia Obon-Santacana, Rish K. Pai, Lori C. Sakoda, Robert E. Schoen, Martha L. Slattery, Wei Sun, Efrat L. Amitay, Elizabeth Alwers, Stephen N. Thibodeau, Amanda E. Toland, Bethany Van Guelpen, Syed H. Zaidi, John D. Potter, Jeffrey A. Meyerhardt, Marios Giannakis, Mingyang Song, Jonathan A. Nowak, Ulrike Peters, Amanda Phipps, Shuji Ogino

Summary: This study analyzed 13,101 colorectal cancer cases and found a significant association between tumor location and molecular features. The detailed colonic location and tumor molecular features play an important role in the prognostication and precision medicine of colon cancer.

JOURNAL OF GASTROENTEROLOGY (2023)

Article Medicine, General & Internal

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies

Thomas Heisser, Jens Kretschmann, Bernd Hagen, Tobias Niedermaier, Michael Hoffmeister, Hermann Brenner

Summary: A study in Germany found that the prevalence of cancer or adenomas at least 10 years after a negative colonoscopy result was low. The extension of the currently recommended 10-year screening intervals may be necessary, especially for female and younger participants without gastrointestinal symptoms.

JAMA INTERNAL MEDICINE (2023)

Article Pathology

Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study

Elizabeth Alwers, Jakob N. Kather, Matthias Kloor, Alexander Brobeil, Katrin E. Tagscherer, Wilfried Roth, Amelie Echle, Efrat L. Amitay, Jenny Chang-Claude, Hermann Brenner, Michael Hoffmeister

Summary: This study examined and validated the association between an immune cell score similar to the Immunoscore and CRC patient survival as well as established molecular tumor markers. The immune cell score was found to be significantly associated with better patient survival, indicating its potential as a strong prognostic marker.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2023)

Letter Gastroenterology & Hepatology

Significant underestimation of preventive effects in colorectal cancer screening trial

Thomas Heisser, Michael Hoffmeister, Hermann Brenner

Article Oncology

Breast cancer screening programmes and self-reported mammography use in European countries

Rafael Cardoso, Michael Hoffmeister, Hermann Brenner

Summary: This study analyzed the key characteristics of breast cancer screening programs and mammography use in European countries. The findings showed significant variations in screening programs and mammography use across different countries, calling for improved utilization of mammography screening across Europe, especially in countries with lower development levels.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Nutrition & Dietetics

Impact of Reducing Intake of Red and Processed Meat on Colorectal Cancer Incidence in Germany 2020 to 2050-A Simulation Study

Tobias Niedermaier, Thomas Gredner, Michael Hoffmeister, Ute Mons, Hermann Brenner

Summary: Consumption of processed meat is carcinogenic, particularly in relation to colorectal cancer risk, according to the IARC. Reducing intake of processed and red meat in Germany can significantly reduce the incidence of colorectal cancer.

NUTRIENTS (2023)

Article Nutrition & Dietetics

Vitamin D Status, Cdx2 Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort

Tafirenyika Gwenzi, Petra Schrotz-King, Ben Schoettker, Michael Hoffmeister, Hermann Brenner

Summary: According to recent evidence, the prognostic value of Vitamin D (VitD) status for colorectal cancer (CRC) patients might be confined to patients with the GG genotype of Cdx2, a functional polymorphism of the VitD receptor gene. In this study, the researchers aimed to validate these findings in a cohort of CRC patients by measuring serum VitD concentration and performing Cdx2 genotyping. The results showed that VitD deficiency is associated with poorer survival, particularly in patients with the GG genotype of Cdx2.

NUTRIENTS (2023)

Article Oncology

The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort

Fatemeh Safizadeh, Marko Mandic, Dianne Pulte, Tobias Niedermaier, Michael Hoffmeister, Hermann Brenner

Summary: This study aimed to investigate the association between excess weight and colorectal cancer (CRC) risk, taking into account prediagnostic weight loss. The results showed that the association between overweight/obesity and CRC risk became stronger with longer follow-up duration, and excluding the initial years of follow-up further strengthened the association. Therefore, the impact of excess weight on CRC risk has been underestimated.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Probing the diabetes and colorectal cancer relationship using gene - environment interaction analyses

Niki Dimou, Andre E. Kim, Orlagh Flanagan, Neil Murphy, Virginia Diez-Obrero, Anna Shcherbina, Elom K. Aglago, Emmanouil Bouras, Peter T. Campbell, Graham Casey, Steven Gallinger, Stephen B. Gruber, Mark A. Jenkins, Yi Lin, Victor Moreno, Edward Ruiz-Narvaez, Mariana C. Stern, Yu Tian, Kostas K. Tsilidis, Volker Arndt, Elizabeth L. Barry, James W. Baurley, Sonja I. Berndt, Stephane Bezieau, Stephanie A. Bien, D. Timothy Bishop, Hermann Brenner, Arif Budiarto, Robert Carreras-Torres, Tjeng Wawan Cenggoro, Andrew T. Chan, Jenny Chang-Claude, Stephen J. Chanock, Xuechen Chen, David V. Conti, Christopher H. Dampier, Matthew Devall, David A. Drew, Jane C. Figueiredo, Graham G. Giles, Andrea Gsur, Tabitha A. Harrison, Akihisa Hidaka, Michael Hoffmeister, Jeroen R. Huyghe, Kristina Jordahl, Eric Kawaguchi, Temitope O. Keku, Susanna C. Larsson, Loic Le Marchand, Juan Pablo Lewinger, Li Li, Bharuno Mahesworo, John Morrison, Polly A. Newcomb, Christina C. Newton, Mireia Obon-Santacana, Jennifer Ose, Rish K. Pai, Julie R. Palmer, Nikos Papadimitriou, Bens Pardamean, Anita R. Peoples, Paul D. P. Pharoah, Elizabeth A. Platz, John D. Potter, Gad Rennert, Peter C. Scacheri, Robert E. Schoen, Yu-Ru Su, Catherine M. Tangen, Stephen N. Thibodeau, Duncan C. Thomas, Cornelia M. Ulrich, Caroline Y. Um, Franzel J. B. van Duijnhoven, Kala Visvanathan, Pavel Vodicka, Ludmila Vodickova, Emily White, Alicja Wolk, Michael O. Woods, Conghui Qu, Anshul Kundaje, Li Hsu, W. James Gauderman, Marc J. Gunter, Ulrike Peters

Summary: Diabetes is a risk factor for colorectal cancer, but the mechanisms and genetic variants affecting this relationship are still unclear. Through genome-wide gene-environment interaction analysis, it was found that variations in insulin signaling gene (SLC30A8) and immune function gene (LRCH1) may modify the association between diabetes and colorectal cancer risk.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients

Hanla A. Park, Dominic Edelmann, Federico Canzian, Petra Seibold, Tabitha A. Harrison, Xinwei Hua, Qian Shi, Allison Silverman, Axel Benner, Angelica Macauda, Martin Schneider, Richard M. Goldberg, Steven R. Alberts, Michael Hoffmeister, Hermann Brenner, Andrew T. Chan, Ulrike Peters, Polly A. Newcomb, Jenny Chang-Claude

Summary: We conducted the first large-scale genome-wide association study to identify genetic variants that can predict the prognosis of colorectal cancer patients undergoing different chemotherapy treatments. Our analysis revealed specific loci associated with overall survival in stage III colon cancer patients and metastatic colorectal cancer patients. These findings may have significant implications for personalized treatment and improved clinical outcomes.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14-24 Years Post-Diagnosis: A Population-Based Study

Melissa S. Y. Thong, Daniela Doege, Linda Weisser, Lena Koch-Gallenkamp, Lina Jansen, Heike Bertram, Andrea Eberle, Bernd Holleczek, Alice Nennecke, Annika Waldmann, Sylke Ruth Zeissig, Hermann Brenner, Volker Arndt

Summary: This study aimed to compare the health-related quality of life (HRQOL) between colorectal cancer (CRC) survivors and non-cancer controls. The results showed that CRC survivors had poorer social functioning but better health status/QOL. They also experienced a higher level of symptom burden, especially diarrhea and constipation, regardless of demographic or clinical factors. HRQOL differed based on factors such as age, sex, cancer type, and having a permanent stoma.

CURRENT ONCOLOGY (2023)

Article Oncology

Associations of smoking with early- and late-onset colorectal cancer

Hengjing Li, Xuechen Chen, Michael Hoffmeister, Hermann Brenner

Summary: The incidence of colorectal cancer (CRC) in younger adults is increasing in many countries. This study aimed to evaluate the association of smoking exposure with early-onset CRC (EOCRC) risk and compare it with late-onset CRC (LOCRC). The results showed that smoking is a strong risk factor for both EOCRC and LOCRC.

JNCI CANCER SPECTRUM (2023)

Review Oncology

Potential of Fecal Carcinoembryonic Antigen for Noninvasive Detection of Colorectal Cancer: A Systematic Review

Xianzhe Li, Lara Stassen, Petra Schrotz-King, Zitong Zhao, Rafael Cardoso, Janhavi R. Raut, Megha Bhardwaj, Hermann Brenner

Summary: This systematic review evaluated fecal carcinoembryonic antigen (FCEA) as a biomarker for the noninvasive diagnosis and diagnosis of colorectal cancer (CRC). The study found significant differences in FCEA levels between CRC and control groups, and the diagnostic performance of FCEA was superior to that of serum carcinoembryonic antigen (SCEA), suggesting its potential role as a novel and easily measurable biomarker for the diagnosis of CRC. However, more comprehensive evaluation in screening settings is needed due to limited evidence from clinical studies.

CANCERS (2023)

Article Oncology

C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy Controls

Mani Etemad, Foteini Christodoulou, Stefanie Uhlig, Jessica C. Hassel, Petra Schrotz-King, Hermann Brenner, Cornelia M. Ulrich, Karen Bieback, Harald Klueter, Peter Bugert

Summary: This study investigated the effect of platelet activation on CLEC-2 expression and sCLEC-2 plasma level. PDPN significantly increased the aggregation response induced by classical agonists. Stimulation of platelets with ADP or PDPN caused a significant decrease in CLEC-2 on platelets and sCLEC-2 in the plasma. The plasma level of sCLEC-2 was lower in most tumor patients, except for glioblastoma patients who displayed higher levels.

CANCERS (2023)

No Data Available